Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha Hurwitz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
New Directions for Student Leadership|August 25, 2020
Integrating Followership Into Leadership ProgramsMarc Hurwitz, Samantha Hurwitz
British Journal of Pharmacology|May 31, 2023
Targeting integrins in drug-resistant acute myeloid leukaemiaHeather A Ogana, Samantha Hurwitz, Nathan Wei, et al.
Cancers|August 14, 2025
Targeting Wnt Signaling in Acute Lymphoblastic LeukemiaSamantha Hurwitz, Ki Jun Lee, Tatiana Fourfouris, et al.
Frontiers in Immunology|May 29, 2026
Wnt signaling as a regulator of memory T cells: implications for CAR-T cell therapyTatiana Fourfouris, Ki Jun Lee, Samantha Hurwitz, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 29, 2023
Altered physical phenotypes of leukemia cells that survive chemotherapy treatmentChau Ly, Heather Ogana, Hye Na Kim, et al.
Frontiers in Cell and Developmental Biology|April 21, 2023
Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemiaHeather A Ogana, Samantha Hurwitz, Chih-Lin Hsieh, et al.
Experimental Hematology|June 23, 2026
Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALLHye Na Kim, Samantha Hurwitz, Tatiana Fourfouris, et al.
Current Molecular Pharmacology|September 11, 2023
A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex INyam-Osor Chimge, Min-Hsuan Chen, Cu Nguyen, et al.
Frontiers in Oncology|December 20, 2021
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic LeukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
New Directions for Student Leadership|August 25, 2020
Integrating Followership Into Leadership ProgramsMarc Hurwitz, Samantha Hurwitz
British Journal of Pharmacology|May 31, 2023
Targeting integrins in drug-resistant acute myeloid leukaemiaHeather A Ogana, Samantha Hurwitz, Nathan Wei, et al.
Cancers|August 14, 2025
Targeting Wnt Signaling in Acute Lymphoblastic LeukemiaSamantha Hurwitz, Ki Jun Lee, Tatiana Fourfouris, et al.
Frontiers in Immunology|May 29, 2026
Wnt signaling as a regulator of memory T cells: implications for CAR-T cell therapyTatiana Fourfouris, Ki Jun Lee, Samantha Hurwitz, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 29, 2023
Altered physical phenotypes of leukemia cells that survive chemotherapy treatmentChau Ly, Heather Ogana, Hye Na Kim, et al.
Frontiers in Cell and Developmental Biology|April 21, 2023
Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemiaHeather A Ogana, Samantha Hurwitz, Chih-Lin Hsieh, et al.
Experimental Hematology|June 23, 2026
Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALLHye Na Kim, Samantha Hurwitz, Tatiana Fourfouris, et al.
Current Molecular Pharmacology|September 11, 2023
A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex INyam-Osor Chimge, Min-Hsuan Chen, Cu Nguyen, et al.
Frontiers in Oncology|December 20, 2021
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic LeukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Pageof 1